Among patients with hypertension at high risk of cardiovascular disease, a program where patients measured their blood pressure and adjusted their antihypertensive medication accordingly resulted in lower systolic blood pressure at 12 months compared with patients who received usual care, according to a study in the Aug. 27 issue of JAMA.
More than 55% of people suffer from swallowing difficulties when taking tablets or capsules, which is likely to inhibit compliance, according to an international survey conducted by Spiegel Institute Mannheim on behalf of Hermes Pharma.
Rx Safes, manufacturer of fingerprint recognition home prescription lockboxes, on Thursday announced that it is waging a new war on drugs to reduce prescription drug abuse, backed by a national media campaign.
The steep decline in the use of hormone therapy has spawned a prevalent but preventable side effect: Millions of women suffering in silence with hot flashes, according to a study by a Yale School of Medicine researcher and colleagues.
Walgreens on Wednesday announced a tetanus, diphtheria, pertussis (Tdap) vaccination voucher program, in collaboration with the Alaska Department of Health and Social Services, to help protect against pertussis (whooping cough).
H. D. Smith on Monday announced the winners of its annual Trading Partners of the Year award, honoring select pharmaceutical and health products manufacturers who collaborate actively to grow the industry and advance patient care.
Canada's Premiers gathered in Charlottetown for the latest Council of the Federation meeting starting on Aug. 26, and health reform is a key topic. The pharmacy community is urging provinces to consider further expanding pharmacists' role as they can make important contributions to improving patient outcomes, reducing costs and ensuring the sustainability of the health care system.
The International Society for Pharmaceutical Engineering on Wednesday announced that it has released a preview of its Drug Shortages Prevention Plan aimed at helping the pharmaceutical industry avoid drug shortages and maintain a reliable supply of medications.
Canadian pharmaceutical company Apotex announced the appointment of Dr. Jeremy Desai to president and CEO. He has spent close to 30 years in a number of senior roles within the pharmaceutical industry and has been with Apotex for the last 11 years.